Compounding II: Equipment, Stability & Excipients — clinical cases
29 questions
Sample cases
- Case 1
A pharmacy in the United States compounds an oral suspension for a 6-year-old boy (weight 21 kg) with epilepsy who cannot swallow tablets. The vehicle is aqueous (water activity ≥ 0.6) and contains an antimicrobial preservative. There is no USP–NF compounded preparation monograph and no stability study for this formulation.
According to USP General Chapter <795> (2023 revision), what is the longest beyond-use date (BUD) that may be assigned?
- A.35 days
- B.14 days
- C.90 days
- D.180 days
- Case 2
A 64-year-old woman with dysphagia after a stroke needs a compounded oral liquid of a drug that is unstable in water. The pharmacist (in the United States) suspends the drug in a medium-chain triglyceride oil with no water added (water activity < 0.6). No stability data or USP–NF monograph exist for this preparation.
According to USP <795> (2023), what is the maximum default BUD?
- A.14 days
- B.35 days
- C.90 days
- D.180 days
- Case 3
A pharmacist in Canada compounds a water-containing cream for a 52-year-old man with chronic hand dermatitis. No stability information exists for the formulation, and it is packaged in an air-tight, light-resistant jar.
According to the NAPRA Model Standards for Pharmacy Compounding of Non-sterile Preparations (2018) guidance document, what is the maximum recommended BUD?
- A.14 days, refrigerated
- B.30 days
- C.35 days
- D.6 months
